News
A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...
American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...
American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...
Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy, Ozempic ...
William Tong has taken legal action against two online distributors, Triggered Brand and Made In China, for allegedly selling research-grade GLP-1 weight loss drugs directly to Connecticut consumers ...
A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...
The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...
The report also underscored the importance of maintaining muscle mass and bone density while losing weight. Since weight loss ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
Explore the evolving landscape of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for obesity, highlighting access challenges and payer coverage trends affecting treatment options.
Despite her active and healthy lifestyle, Sasha Barden felt stuck in her weight loss journey. She decided to try GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results